Primary Site >> Biliary tract Cancer

Overview

Mutation

Expression

Methylation

Prognosis

Literature

Timeline

Gene >> IKZF3

2012	2014	2018
Ref: Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany. PMID: 23207621	Ref: Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme. PMID: 25446376	Ref: PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study. PMID: 29413685